Skip to main content
SpringerLink
Log in

How and why vaccines are made

  • Chapter
The Grand Challenge for the Future

Part of the book series: Birkhäuser Advances in Infectious Diseases BAID ((BAID))

  • 700 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anonymous (2003) Infectious diseases in children. Slack Inc., Thorofare, NJ, August, 19

    Google Scholar 

  2. Mahoney RT, Pablos-Mendez A, Ramachandran S (2004) The introduction of new vaccines into developing countries. III. The role of intellectual property. Vaccine 22: 786–792

    Article  PubMed  Google Scholar 

  3. Ellis RW (2001) Technologies for the design, discovery, formulation and administration of vaccines. Vaccine 19: 2681–2687

    PubMed  CAS  Google Scholar 

  4. Plotkin SA (2003) Vaccines, vaccination, and vaccinology. J Infect Dis 187: 1349–1359

    Article  PubMed  CAS  Google Scholar 

  5. Plotkin SA (2005) Six revolutions in vaccinology. Pediatric Inf Dis J 24: 1–9

    Google Scholar 

  6. Marcuse EK (1998) United States vaccine research: a delicate fabric of public and private collaboration. Pediatrics 102: 1002–1003

    Article  PubMed  CAS  Google Scholar 

  7. Douglas RG (1996) Fostering partnerships for vaccine development: a delicate fabric. Bull NY Acad Med 73: 113–123

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical and Scientific Advisor, Sanofi Pasteur, University of Pennsylvania, 4650 Wismer Road, Doylestown, PA, 18901, USA

    Stanley A. Plotkin (Emeritus Professor of Pediatrics)

  2. Industrial Operations, Sanofi Pasteur, Inc., Discovery Drive, Swiftwater, PA, 18370, USA

    James M. Robinson (Vice President)

Authors
  1. Stanley A. Plotkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James M. Robinson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Max Planck Institute for Infection Biology, Schumannstrasse 21-22, D-10117, Berlin, Germany

    Stefan H.E. Kaufmann

  2. CMU — Centre of Vaccinology, 1 rue Michel Servet, CH-1211, Geneva 4, Switzerland

    Paul-Henri Lambert

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Plotkin, S.A., Robinson, J.M. (2005). How and why vaccines are made. In: Kaufmann, S.H., Lambert, PH. (eds) The Grand Challenge for the Future. Birkhäuser Advances in Infectious Diseases BAID. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7381-4_2

Download citation

  • DOI: https://doi.org/10.1007/3-7643-7381-4_2

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-7643-7175-3

  • Online ISBN: 978-3-7643-7381-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation